[{"address1": "1111 Kane Concourse", "address2": "Suite 301", "city": "Bay Harbor Islands", "state": "FL", "zip": "33154", "country": "United States", "phone": "781 652 4500", "website": "https://www.avenuetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alexandra  MacLean M.D.", "age": 57, "title": "CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 433800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Jin", "age": 33, "title": "Interim CFO, COO & Corporate Secretary", "yearBorn": 1991, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald M.D.", "age": 69, "title": "Executive Director", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott A. Reines M.D., Ph.D.", "age": 77, "title": "Interim Chief Medical Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 69120, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5279, "open": 0.47, "dayLow": 0.47, "dayHigh": 0.51, "regularMarketPreviousClose": 0.5279, "regularMarketOpen": 0.47, "regularMarketDayLow": 0.47, "regularMarketDayHigh": 0.51, "payoutRatio": 0.0, "beta": -0.09, "forwardPE": -0.1264968, "volume": 5716, "regularMarketVolume": 5716, "averageVolume": 7115, "averageVolume10days": 14609, "averageDailyVolume10Day": 14609, "bid": 0.45, "ask": 0.61, "bidSize": 3891, "askSize": 3543, "marketCap": 1264525, "fiftyTwoWeekLow": 0.1653, "fiftyTwoWeekHigh": 3.54, "fiftyDayAverage": 0.2849912, "twoHundredDayAverage": 1.0383558, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3415473, "profitMargins": 0.0, "floatShares": 2832802, "sharesOutstanding": 3183600, "sharesShort": 59696, "sharesShortPriorMonth": 154915, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.028299998, "heldPercentInsiders": 0.1841, "heldPercentInstitutions": 0.03154, "shortRatio": 0.65, "shortPercentOfFloat": 0.028299998, "impliedSharesOutstanding": 3183600, "bookValue": 1.103, "priceToBook": 0.36010876, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -9164000, "trailingEps": -1.01, "forwardEps": -3.14, "lastSplitFactor": "1:75", "lastSplitDate": 1714089600, "52WeekChange": -0.84839696, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 0.3972, "recommendationKey": "none", "totalCash": 3502000, "totalCashPerShare": 1.1, "totalDebt": 0, "quickRatio": 2.775, "currentRatio": 2.848, "returnOnAssets": -1.7164, "returnOnEquity": -4.35225, "freeCashflow": -4821000, "operatingCashflow": -7092000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ATXI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "earningsTimestamp": 1747339200, "earningsTimestampStart": 1754564340, "earningsTimestampEnd": 1754913600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -3.14, "fiftyDayAverageChange": 0.11220878, "fiftyDayAverageChangePercent": 0.39372718, "twoHundredDayAverageChange": -0.64115584, "regularMarketChange": -0.13069999, "regularMarketDayRange": "0.47 - 0.51", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 7115, "fiftyTwoWeekLowChange": 0.23189999, "fiftyTwoWeekLowChangePercent": 1.4029038, "fiftyTwoWeekRange": "0.1653 - 3.54", "fiftyTwoWeekHighChange": -3.1427999, "fiftyTwoWeekHighChangePercent": -0.8877966, "fiftyTwoWeekChangePercent": -84.8397, "marketState": "CLOSED", "exchange": "PNK", "messageBoardId": "finmb_310815442", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -24.758478, "regularMarketPrice": 0.3972, "shortName": "Avenue Therapeutics, Inc.", "longName": "Avenue Therapeutics, Inc.", "corporateActions": [{"header": "Delisting", "message": "ATXI is delisted effective Jul. 28, 2025", "meta": {"eventType": "DELISTING", "dateEpochMs": 1753675200000}}], "regularMarketTime": 1753401600, "hasPrePostMarketData": false, "twoHundredDayAverageChangePercent": -0.6174722, "cryptoTradeable": false, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1498570200000, "displayName": "Avenue Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]